Baijin Life Science Holdings Limited (MNNGF)
Baijin Life Science Holdings Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Consumer Cyclical sector, headquartered in Hong Kong, HK. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $74.6M. On trailing twelve-month figures it carries a trailing P/E of -25.75, a net margin of -42.4%. Its beta of -0.31 implies it has historically moved less than the broad market.
This investment holding company specializes in a comprehensive range of activities within the pearl and jewelry industry, encompassing everything from sourcing, processing, and design to manufacturing, assembly, trading, and wholesale distribution of these products. Its operations are bifurcated into two main divisions: the sale of pearls and jewelry, and strategic investment and financial services. Additionally, the company participates in real estate financial asset investments. Its global footprint includes Hong Kong, the United Kingdom, the United States, Japan, Europe, and mainland China. Originally named Man Sang Jewellery Holdings Limited, the firm adopted the identity of Affluent Partners Holdings Limited in February 2017. Established in 2014, its headquarters are situated in Central, Hong Kong.
Baijin Life Science Holdings Limited is most often compared with the following Consumer Cyclical names: